Peptomyc Board of Directors appoints Giacomo Di Nepi as Chairman of the Board
Peptomyc Board of Directors appoints Giacomo Di Nepi as Chairman of the Board
BARCELONA, Spain, Jan. 07, 2021 Peptomyc S.L., a biotech company specialized in the development of protein and peptide therapeutics targeting the Myc oncoprotein for cancer treatment, announces today that has appointed veteran pharma and biotech executive
Giacomo Di Nepi as
Mr. Di Nepi has accumulated nearly
40 years of global experience in the Healthcare sector. His career started with 16 years at McKinsey & Company, where he was a Partner and Core Leadership member of the Global Pharmaceutical Practice, followed by 11 years at